Richard Law CFA
Stock Analyst at Goldman Sachs
(0.99)
# 3,953
Out of 5,082 analysts
135
Total ratings
36.2%
Success rate
-2.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Richard Law CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Reiterated: Buy | $42 | $17.76 | +136.49% | 6 | Oct 19, 2026 | |
| RCKT Rocket Pharmaceuticals | Upgraded: Hold | $3 → $4 | $2.28 | +75.44% | 8 | Oct 8, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Hold | $28 | $29.50 | -5.08% | 9 | Oct 5, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Hold | $33 → $38 | $24.21 | +56.96% | 3 | Sep 22, 2026 | |
| OLMA Olema Pharmaceuticals | Reiterated: Buy | $20 → $18 | $6.62 | +171.90% | 11 | Sep 14, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $186 | $140.32 | +32.55% | 8 | Aug 31, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $39 → $40 | $23.34 | +71.38% | 11 | Aug 19, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | $42 → $40 | $20.56 | +94.55% | 13 | Aug 12, 2026 | |
| BCAX Bicara Therapeutics | Rated: Hold | $18 → $20 | $16.89 | +18.41% | 5 | Aug 11, 2026 | |
| SLN Silence Therapeutics | Reiterated: Sell | $4 | $19.78 | -79.78% | 4 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $46 | $36.02 | +27.71% | 2 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 → $12 | $11.81 | +1.61% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $29 → $33 | $31.81 | +3.74% | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $31 | $8.45 | n/a | 6 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 | $23.79 | n/a | 4 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 → $63 | $49.01 | n/a | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $37 | $114.84 | n/a | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $11.26 | n/a | 7 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $10.48 | n/a | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $7.31 | n/a | 5 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $14 | $2.40 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $10 | $2.98 | n/a | 2 | Feb 24, 2023 |
Arcus Biosciences
Oct 19, 2026
Reiterated: Buy
Price Target: $42
Current: $17.76
Upside: +136.49%
Rocket Pharmaceuticals
Oct 8, 2026
Upgraded: Hold
Price Target: $3 → $4
Current: $2.28
Upside: +75.44%
Celldex Therapeutics
Oct 5, 2026
Reiterated: Hold
Price Target: $28
Current: $29.50
Upside: -5.08%
Viking Therapeutics
Sep 22, 2026
Reiterated: Hold
Price Target: $33 → $38
Current: $24.21
Upside: +56.96%
Olema Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $20 → $18
Current: $6.62
Upside: +171.90%
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $186
Current: $140.32
Upside: +32.55%
Viridian Therapeutics
Aug 19, 2026
Reiterated: Buy
Price Target: $39 → $40
Current: $23.34
Upside: +71.38%
Mineralys Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $42 → $40
Current: $20.56
Upside: +94.55%
Bicara Therapeutics
Aug 11, 2026
Rated: Hold
Price Target: $18 → $20
Current: $16.89
Upside: +18.41%
Silence Therapeutics
Jul 27, 2026
Reiterated: Sell
Price Target: $4
Current: $19.78
Upside: -79.78%
Jul 13, 2026
Reiterated: Buy
Price Target: $36 → $46
Current: $36.02
Upside: +27.71%
May 11, 2026
Reiterated: Sell
Price Target: $11 → $12
Current: $11.81
Upside: +1.61%
Feb 27, 2026
Reiterated: Hold
Price Target: $29 → $33
Current: $31.81
Upside: +3.74%
Aug 15, 2023
Reiterated: Hold
Price Target: $36 → $31
Current: $8.45
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $47
Current: $23.79
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: $62 → $63
Current: $49.01
Upside: n/a
Aug 4, 2023
Reiterated: Hold
Price Target: $36 → $37
Current: $114.84
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $76
Current: $11.26
Upside: n/a
May 12, 2023
Reiterated: Hold
Price Target: $11
Current: $10.48
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $61
Current: $7.31
Upside: n/a
May 5, 2023
Reiterated: Hold
Price Target: $15 → $14
Current: $2.40
Upside: n/a
Feb 24, 2023
Upgraded: Hold
Price Target: $10
Current: $2.98
Upside: n/a